Market News & Trends
Lhasa & Optibrium Enter Research & Product Development Collaboration
Optibrium and Lhasa Limited recently announced they have formed a collaborative partnership to research next-generation drug metabolism modelling. Results from the work will be used…
LDC & SOTIO Enter License & Collaboration Agreement
The Lead Discovery Center GmbH (LDC), Max Planck Innovation GmbH (MI), and SOTIO a.s. have signed a collaboration and license agreement providing SOTIO with exclusive…
Aptar Pharma Unveils its eDose Counter for MDIs at RDD Europe 2017
Aptar Pharma recently announced it will present its patented eDose Counter for Metered Dose Inhalers (MDIs), designed to be easy-to-use and reliable, and contributes to…
Vectura Group Launches Utibron Neohaler in the US
Vectura Group plc recently announced that Sunovion Pharmaceuticals Inc. has launched Utibron Neohaler (indacaterol/glycopyrrolate) in the US. Sunovion entered into an exclusive license agreement with…
UroGen Pharma Announces Enrollment of First Patient in Phase III Clinical Trial
UroGen Pharma Ltd. recently announced the first patient has been enrolled in the OLYMPUS trial, an open-label, single-arm pivotal Phase III clinical trial of MitoGel,…
Tetraphase Pharmaceuticals Completes Enrollment of IGNITE4 Phase III Clinical Trial
Tetraphase Pharmaceuticals, Inc. recently announced completion of enrollment in IGNITE4, its ongoing Phase III clinical trial evaluating the efficacy and safety of intravenous (IV) eravacycline…
SteadyMed Completes Clinical Validation Study of Trevyent Study; Confirms Performance of PatchPump Technology
SteadyMed Ltd. recently announced the successful completion of a clinical study for its lead drug product candidate, Trevyent. Trevyent is a combination of the company’s…
Caris Life Sciences Announces Study Results for ADAPT Biotargeting System
Caris Life Sciences recently announced results of a study that demonstrate the ability of the company's ADAPT Biotargeting System to identify the molecular target, a…
Bio-Path Holdings Presents Study Results Showing Potential of BP1002
Bio-Path Holdings, Inc. recently announced results of preclinical in vitro and in vivo studies supporting the potential of BP1002 in the treatment of aggressive non-Hodgkin’s…
Aptar Pharma Unveils its eDose Counter for MDIs at RDD Europe 2017
Aptar Pharma recently announced it will present its patented eDose Counter for Metered Dose Inhalers (MDIs), designed to be easy-to-use and reliable, and contributes to…
MedCision Announces the ThawSTAR Early Adopter Program for Limited Time
MedCision, a leader in the automation of basic clinical processes, recently announced the ThawSTAR Cell Thawing Early Adopter Program for companies undergoing early cell therapy…
MedCision Announces the ThawSTAR Early Adopter Program for Limited Time
MedCision, a leader in the automation of basic clinical processes, recently announced the ThawSTAR Cell Thawing Early Adopter Program for companies undergoing early cell therapy…
HealthFactors Announces Collaboration With Koronis Biomedical Technologies
HealthFactors, Inc. and Koronis Biomedical Technologies (KBT) recently announced a formal collaboration designed to improve healthcare and outcomes for people with respiratory conditions associated with…
HealthFactors Announces Collaboration With Koronis Biomedical Technologies
HealthFactors, Inc. and Koronis Biomedical Technologies (KBT) recently announced a formal collaboration designed to improve healthcare and outcomes for people with respiratory conditions associated with…
Cellect Announces Successful First Cancer Patient Stem Cell Transplant
Cellect Biotechnology Ltd. recently announced that the first stem cell transplant procedure has been successfully performed using its ApoGraft technology in the company’s Phase I/II…
Permira Funds to Acquire Leading CDMO Lyophilization Services of New England
Permira, the global private equity firm, recently announced that a company backed by the Permira funds has signed a definitive agreement to acquire Lyophilization Services…
Opiant Pharmaceuticals Announces Results of PET Study of Nasal Spray
Opiant Pharmaceuticals, Inc. recently announced the completion of a study evaluating two doses of a naloxone nasal spray on the occupation of brain opiate receptors…
Calithera to Receive $12-Million Milestone Payment From Incyte
Calithera Biosciences, Inc. recently announced it has achieved pharmacokinetic and pharmacodynamic goals for CB-1158 which, under its agreement with Incyte Corporation, entitles the company to…
ZIOPHARM Announces Successful End-of-Phase II Meeting With FDA
ZIOPHARM Oncology, Inc. recently announced the receipt of positive guidance from an End-of-Phase II meeting with the US FDA for its lead gene therapy product…
Apeiron Biologics Receives Green Light for Marketing Approval
Apeiron Biologics recently announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval…
